NHS England: Clinical commissioning policy statement for the treatment of drug-resistant TB

The National Health Service (NHS) in England released Clinical commissioning policy statement, and accompanying documents, for the treatment for defined patients with rifampicin-resistant TB, multidrug-resistant TB, pre-extensively drug-resistant TB and extensively drug-resistant TB including bedaquiline and delamanid (all ages).

Access the documents here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By NHS England

Published: June 28, 2024, 7:59 p.m.

Last updated: July 1, 2024, 7:01 p.m.

Print Share